Kinsa's predictive map of COVID-19 outbreaks on Oct. 14, with flashing lights indicating states where cases are projected to rise. Credit: Kinsa

A company that makes internet-connected thermometers has shown success in predicting likely COVID-19 hot spots days or even weeks before case counts rise.

Why it matters: Even as the U.S. has ramped up coronavirus testing, too often we're still behind the pace of the virus. But connected, at-home diagnostics could give advance warning of when COVID-19 — or the next new virus — is about to strike.

Driving the news: The total number of COVID-19 cases in the U.S. this week hit the highest level since August, driven by uncontrolled outbreaks in the Midwest and Mountain West.

How it works: The smart thermometer company Kinsa offers a different way to track — and even predict — the spread of COVID-19.

  • Its 1.5 million connected thermometers provide real-time data about fevers around the U.S., which can be compared to historical rates of seasonal illnesses like the flu to indicate "when something unusual is happening," says Kinsa CEO Inder Singh.
  • Kinsa's own data from the start of the pandemic shows spikes of atypical fevers peaking two to three weeks before the first recorded COVID-19 deaths in New York City — a clear early warning the outbreak was blooming.

What to watch: The system's model is predicting case increases in more than 20 states over the next four weeks, including states like Oregon, New York and Maryland that currently have low case numbers.

What they're saying: "Advance warning matters," says Singh. "If the U.S. had shut down a week earlier than it did in the spring, it would have saved tens of thousands of lives."

What's next: To get granular national coverage for COVID-19 and beyond, Kinsa would need to distribute 5.4 million thermometers.

  • Singh says it would cost $135 million initially, but governments have been slow to provide funding.

The bottom line: COVID-19 has taught us the value of being able to predict outbreaks in advance — and the price of being unprepared.

Go deeper

How the coronavirus pandemic could end

Illustration: Sarah Grillo/Axios

It's still the early days of the coronavirus pandemic, but history, biology and the knowledge gained from our first nine months with COVID-19 point to how the pandemic might end.

The big picture: Pandemics don't last forever. But when they end, it usually isn't because a virus disappears or is eliminated. Instead, they can settle into a population, becoming a constant background presence that occasionally flares up in local outbreaks.

Updated 17 hours ago - World

France becomes 2nd Western European country to top 1M coronavirus cases

French President Emmanuel Macron at the Seine Saint Denis prefecture headquarters in Paris, on Tuesday. Photo: Ludovic Marin/POOL/AFP via Getty Images

France has become the second country in Western Europe to surpass 1 million COVID-19 cases, Johns Hopkins University data shows

The big picture: France had reported 1,000,369 cases and 34,075 deaths from the coronavirus by Thursday morning, per JHU. French President Emmanuel Macron declared a state of health emergency and imposed a curfew on virus hot spots earlier this month. Spain on Wednesday became the first Western European nation to top 1 million cases.

13 hours ago - Health

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.